Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial-Reference-Cited by-同舟云学术

Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial

Published:2005-12 Issue:9502 Volume:366 Page:2012-2018
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Alonso Pedro L,Sacarlal Jahit,Aponte John J,Leach Amanda,Macete Eusebio,Aide Pedro,Sigauque Betuel,Milman Jessica,Mandomando Inacio,Bassat Quique,Guinovart Caterina,Espasa Mateu,Corachan Sabine,Lievens Marc,Navia Margarita M,Dubois Marie-Claude,Menendez Clara,Dubovsky Filip,Cohen Joe,Thompson Ricardo,Ballou W Ripley

Publisher

Elsevier BV

Subject

General Medicine

Reference16 articles.

1. Vaccines for preventing malaria;Graves;Cochrane Database Syst Rev,2003

2. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria;Stoute;N Engl J Med,1997

3. Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria;Kester;J Infect Dis,2001

4. Safety and immunogenicity of RTS,S/AS02A candidate malaria vaccine in Gambian children;Bojang;Vaccine,2005

5. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial;Alonso;Lancet,2004

Cited by 329 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccines and monoclonal antibodies: new tools for malaria control;Clinical Microbiology Reviews;2024-06-13

2. A replication competent Plasmodium falciparum parasite completely attenuated by dual gene deletion;EMBO Molecular Medicine;2024-03-21

3. Structure–Activity Relationship of a Pyrrole Based Series of PfPKG Inhibitors as Anti-Malarials;Journal of Medicinal Chemistry;2024-02-19

4. Malaria Vaccines: Progress to Date;BioDrugs;2023-09-20

5. A non-replicative antibiotic resistance-free DNA vaccine delivered by the intranasal route protects against canine leishmaniasis;Frontiers in Immunology;2023-09-18